Malte Schwartz

Works (3)

Updated: July 5th, 2023 15:46

2013 journal article

Assessment of the prevalence and clinical features of cryptogenic epilepsy in dogs: 45 cases (2003-2011)

JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 242(5), 651–657.

By: M. Schwartz n, K. Munana*  & J. Nettifee-Osborne*

Contributors: M. Schwartz n, K. Muñana*  & J. Nettifee-Osborne*

MeSH headings : Animals; Dog Diseases / diagnosis; Dogs; Epilepsy / diagnosis; Epilepsy / veterinary; Female; Longevity; Male; Retrospective Studies
TL;DR: Cryptogenic epilepsy was diagnosed in a substantial proportion of dogs with an onset of epileptic seizures at ≥ 7 years of age and was considered acceptable in most dogs. (via Semantic Scholar)
UN Sustainable Development Goal Categories
1. No Poverty (OpenAlex)
Sources: Web Of Science, ORCID
Added: August 6, 2018

2013 journal article

The pharmacokinetics of midazolam after intravenous, intramuscular, and rectal administration in healthy dogs

JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 36(5), 471–477.

By: M. Schwartz n, K. Munana n , J. Nettifee-Osborne n, K. Messenger n & M. Papich n 

Contributors: M. Schwartz n, K. Muñana n , J. Nettifee-Osborne n, K. Messenger n & M. Papich n 

MeSH headings : Administration, Rectal; Animals; Anticonvulsants / administration & dosage; Anticonvulsants / blood; Anticonvulsants / pharmacokinetics; Chromatography, High Pressure Liquid; Dogs; Female; Injections, Intramuscular / veterinary; Injections, Intravenous / veterinary; Male; Midazolam / administration & dosage; Midazolam / blood; Midazolam / pharmacokinetics
TL;DR: It is suggested that IM midazolam might be useful in treating seizures in dogs when venous access is unavailable, but higher doses may be needed to account for intermediate bioavailability. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Sources: Web Of Science, ORCID
Added: August 6, 2018

2011 journal article

Possible Drug-Induced Hepatopathy in a Dog Receiving Zonisamide Monotherapy for Treatment of Cryptogenic Epilepsy

JOURNAL OF VETERINARY MEDICAL SCIENCE, 73(11), 1505–1508.

By: M. Schwartz n, K. Munana n  & N. Olby n 

Contributors: M. Schwartz n, K. Muñana n  & N. Olby n 

author keywords: antiepileptic drug; canine; idiosyncratic drug reaction; liver; seizure
MeSH headings : Animals; Anticonvulsants / adverse effects; Anticonvulsants / therapeutic use; Chemical and Drug Induced Liver Injury / diagnosis; Chemical and Drug Induced Liver Injury / veterinary; Dog Diseases / chemically induced; Dog Diseases / diagnosis; Dog Diseases / drug therapy; Dogs; Epilepsy / drug therapy; Epilepsy / veterinary; Female; Isoxazoles / adverse effects; Isoxazoles / therapeutic use; Zonisamide
TL;DR: If signs of hepatotoxicity are recognised early and zonisamide is discontinued, complete recovery is possible and Veterinary practitioners and owners should be educated about the potential for an idiosyncratic drug reaction to Zonisamide. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Sources: Web Of Science, ORCID
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.